Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linifanib vs Sorafenib in Advanced HCC
NCT01009593Phase 3Terminated
- Sponsor
- Abbott Laboratories
- Start
- Jan 2010
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 29
01
Overview
A Phase 3 trial of linifanib in hepatocellular carcinoma (HCC), sponsored by Abbott Laboratories. Started Jan 2010; status: terminated.
02
Drugs
linifanib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01009593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01009593.